News

04/04/2024

Psychosis in Parkinson’s disease is not only associated with the use of dopaminergic medications, but it is also part of the disease process itself

A study conducted by researchers from the Parkinson's Disease and Movement Disorders Research Group at the Sant Pau Research Institute, led by Drs. Jaume Kulisevsky and Javier Pagonabarraga, has concl...

21/03/2024

Dr. Juan Fortea addresses the challenges and advances in health care for people with Down syndrome in a featured editorial in ‘The Lancet’

The prestigious journal The Lancet has invited Dr. Juan Fortea, director of the research area in Neurological Diseases, Neuroscience, and Mental Health at the Sant Pau Research Institute, and director...

20/03/2024

Sant Pau initiates a pioneering study on the potential benefits of sports in Parkinson’s patients

The Parkinson's Disease and Movement Disorders Research Group at the Sant Pau Research Institute (IR Sant Pau) has launched a scientific study to evaluate the potential cognitive, motor, and emotional...

15/03/2024

Myasthenia gravis meeting at Sant Pau

Dr. Eduard Gallardo, a researcher from the Neuromuscular Diseases group at the Sant Pau Research Institute, hosted the "F2F meeting OptiMyG," a gathering that brought together various professionals to...

08/03/2024

Anna Aulinas, recognized within the European sphere as a Rising Star

Dr. Anna Aulinas, coordinator of the Pituitary Diseases Unit at the Hospital de Sant Pau, researcher in the Pituitary Diseases group at the Sant Pau Research Institute, and member of Unit 747 of CIBER...